TLR3 and neoplasm: Indeed, we have recently confirmed that Ly6AE-upregulation on CD8 T cells occurs in a strictly IFN-α/β-dependent manner after AB1-HA tumor treatment with the TLR3 and TLR7 agonists poly-I:C and imiquimod [5], [23].